Primary Open-Angle Glaucoma: Clinical Trials

57 trials for Primary Open-Angle Glaucoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed, 9 unknown, 4 terminated, 3 recruiting. 21 Not applicable, 10 Phase 2, 6 Phase 1, 5 Phase 3, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable21Completed 13, Terminated 2, Unknown 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1
Phase 210Completed 8, Recruiting 1, Unknown 1
Phase 16Completed 3, Unknown 2, Terminated 1
Phase 35Completed 3, Terminated 1, Unknown 1
Phase 45Completed 4, Unknown 1

Follow Primary Open-Angle Glaucoma: new trials by email Literature Review of Primary Open-Angle Glaucoma trials Research Report on Primary Open-Angle Glaucoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PureSee EDOF Versus ZCB00 Monofocal IOLs in Mild-to-Moderate Glaucoma
TECNIS PureSee Intraocular Lens, TECNIS ZCB00 Monofocal Intraocular Lens - Primary Open-Angle Glaucoma
Not yet recruitingMann Eye Institute1002026-12-022026-11-09
Combined Phacoemulsification-Goniotomy in Primary Open-Angle and Primary Angle-Closure Glaucoma
Combined Phacoemulsification and Goniotomy - Primary Open-Angle Glaucoma, Primary Angle-Closure Glaucoma
Not applicableNot yet recruitingAssiut University702026-10-012026-09-16
A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy
G01 Eye Drops 100μg/ml, G01 Eye Drops 200μg/ml, Placebo of G01 Eye Drops - Primary Open-Angle Glaucoma, Optic Nerve Injury
Phase 2RecruitingQingdao WanMing BioCell Pharmaceutics Co.,Ltd.902026-03-182026-08-24
Effects of Primary Open-angle Glaucoma on Visual-motor Coordination
Primary Open-angle Glaucoma
UnknownZhongshan Ophthalmic Center, Sun Yat-sen University2002024-11-212024-11-18
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma
TimoD implant, Injector system - Primary Open-angle Glaucoma
Phase 1TerminatedEyeD Pharma12023-03-012025-07-16
MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract
Phacoemulsification combined with minimally invasive glaucoma surgery (MIGS) - Primary Open-angle Glaucoma, Cataract
Not applicableEnrolling by invitationiSTAR Medical302023-01-182025-02-28
GORE Glaucoma Drainage Implant Clinical Study Dominican Republic
Gore Glaucoma Device Implant (GORE GDI) - Primary Open-angle Glaucoma
Not applicableActive not recruitingW.L.Gore & Associates302022-09-142026-02-19
Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma
Glycocheck, Ophthalmological examinations - Primary Open-angle Glaucoma, Glaucoma
RecruitingFondation Ophtalmologique Adolphe de Rothschild1002022-05-062025-12-08
GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma
GlaucoT Glaucoma Treatment Device - Primary Open-Angle Glaucoma
Not applicableCompletedGlaucot Teknoloji Anonim Sirketi152022-03-012024-11-18
Effect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle Glaucoma
Acupuncture - Primary Open-angle Glaucoma
Not applicableCompletedChina Medical University Hospital402022-02-282024-04-10
Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl
Eybelis ophthalmic solution 0.002% - Normal Tension Glaucoma, Primary Open-angle Glaucoma
Phase 4UnknownSanten Pharmaceutical Asia Pte. Ltd.1502022-02-152022-03-15
Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD
Switching the preserved prostaglandin analog-timolol FC to Fixalpost (preservative free prostaglandin analog-timolol FC) - Primary Open-angle Glaucoma, Ocular Hypertension
Not applicableUnknownKlinički Bolnički Centar Zagreb502021-03-082021-05-18
BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension
BREMEN eye drops, Combigan® - Ocular Hypertension, Primary Open-angle Glaucoma
Phase 3CompletedEMS4062021-02-012024-02-20
Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients
Primary Open-angle Glaucoma, Primary Angle-Closure Glaucoma
UnknownSanten Pharma Malaysia Sdn Bhd4002020-11-012020-10-30
Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT)
selective laser trabeculoplasty (SLT) - Primary Open-angle Glaucoma
Not applicableCompletedCarl Zeiss Meditec AG372020-06-302024-12-19
PRESERFLO® MicroShunt Extension Study
PRESERFLO® MicroShunt, Trabeculectomy - Primary Open-angle Glaucoma
CompletedInnFocus Inc.2792020-05-222024-03-22
SIGHT Study: Cost-effectiveness of InnFocus Microshunt Implantation vs. Trabeculectomy.
PRESERFLO Microshunt implantation, Trabeculectomy - Primary Open-angle Glaucoma
Not applicableUnknownMaastricht University Medical Center1242020-02-012024-03-19
Decorin in Sub Scleral Trabeculectomy
Decorin, Mitomycin c - Primary Open-angle Glaucoma
Phase 1UnknownCairo University522019-09-012019-04-23
Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension
Levobetaxolol eye drops, Betaxolol eye drops - Primary Open-angle Glaucoma, Ocular Hypertension
Phase 3CompletedZhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.3662019-01-042023-05-12
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
CKD-351, Latanoprost, D930 - Primary Open-angle Glaucoma, Ocular Hypertension
Phase 3UnknownChong Kun Dang Pharmaceutical3842018-12-072018-12-03

Showing 20 of 57. Sign in to see all of them.

Narrower conditions

Glaucoma, Open-Angle (57)  ·  Ocular Hypertension (18)  ·  Glaucoma (14)  ·  Cataract (5)  ·  Exfoliation Syndrome (3)  ·  Low Tension Glaucoma (3)  ·  Glaucoma, Angle-Closure (2)  ·  Retinal Degeneration (2)  ·  Sleep Apnea, Obstructive (2)  ·  Choroidal Effusions (1)  ·  Geographic Atrophy (1)  ·  Optic Atrophy (1)  ·  Optic Nerve Diseases (1)  ·  Optic Nerve Injuries (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Eye Diseases (57)  ·  Glaucoma (43)  ·  Ocular Hypertension (39)  ·  Lens Diseases (5)  ·  Nervous System Diseases (4)  ·  Optic Nerve Diseases (4)  ·  Uveal Diseases (4)  ·  Iris Diseases (3)  ·  Retinal Diseases (3)  ·  Apnea (2)  ·  Cranial Nerve Diseases (2)  ·  Dyssomnias (2)  ·  Eye Diseases, Hereditary (2)  ·  Respiration Disorders (2)  ·  Respiratory Tract Diseases (2)

Interventions

Bimatoprost (5)  ·  Latanoprost (4)  ·  Trabeculectomy (4)  ·  Cataract Extraction (3)  ·  Timolol (3)  ·  Brimonidine Tartrate (2)  ·  Acupuncture Therapy (1)  ·  Benzalkonium Compounds (1)  ·  Brimonidine Tartrate, Timolol Maleate Drug Combination (1)  ·  Continuous Positive Airway Pressure (1)  ·  Culture Techniques (1)  ·  Decorin (1)  ·  Drugs, Investigational (1)  ·  LX-7101 (1)  ·  Lasers (1)

Sponsors

ForSight Vision5, Inc. (4)  ·  Glaukos Corporation (4)  ·  Alcon Research (2)  ·  Wills Eye (2)  ·  Allergan (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Assiut University (1)  ·  Cairo University (1)  ·  Carl Zeiss Meditec AG (1)  ·  Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation (1)  ·  China Medical University Hospital (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  EMS (1)  ·  EyeD Pharma (1)  ·  Fondation Ophtalmologique Adolphe de Rothschild (1)

Countries

United States (19)  ·  China (4)  ·  Egypt (4)  ·  Germany (4)  ·  France (3)  ·  South Korea (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Italy (2)  ·  Spain (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  Colombia (1)  ·  Croatia (1)

Top investigators

Michelle Chen, PhD (4)  ·  Kerry Stephens, O.D. (2)  ·  Ahmed AM Gad, MD (1)  ·  Alejo Peyret, PhD (1)  ·  Alina K Drakon, MD (1)  ·  Anastasios G Konstas, MD, PhD (1)  ·  Anna Grau (1)  ·  Ching-Liang Hsieh, Ph.D (1)  ·  Constantine D Georgakopoulos, MD, PhD (1)  ·  Daniel Grigera, PhD (1)  ·  Daniel Lee, MD (1)  ·  Dariusz Wozniak, MBBS, MRCP (1)  ·  Doreen Schmidl, MD,PhD (1)  ·  Eng Hui Gan, Specialist (1)

Results publications

PMID 17191187, PMID 21851167, PMID 28454526, PMID 28528010, PMID 29781833, PMID 30488265, PMID 30727982, PMID 33469852, PMID 34041935, PMID 35076329, PMID 35943114, PMID 36572747, PMID 36721130, PMID 39510809, PMID 41737851

NIH funding

P30AG022838 (1)